Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-894
Closed -$208K 76
2019
Q3
$208K Sell
894
-3,722
-81% -$867K 0.83% 59
2019
Q2
$1.08M Sell
4,616
-233
-5% -$53.8K 0.71% 58
2019
Q1
$1.15M Sell
4,849
-702
-13% -$221K 0.78% 56
2018
Q4
$1.67M Sell
5,551
-20,433
-79% -$6.52M 1.07% 24
2018
Q3
$9.18M Sell
25,984
-434
-2% -$149K 4.63% 1
2018
Q2
$7.67M Buy
26,418
+412
+2% +$116K 4.6% 1
2018
Q1
$7.12M Buy
26,006
+22
+0.1% +$6.83K 8.67% 1
2017
Q4
$8.28M Buy
+25,984
New +$8.34M 10.72% 1

Other funds holding BIIB

Signition LP's BIIB Position: Q4 2019 in Review

Signition LP sold out of Biogen (BIIB) in Q4 2019, closing a stake of 894 shares — an estimated $208K sold.

Signition LP first reported a position in BIIB in Q4 2017 and held it in 8 quarters. The position peaked at $9.18M in Q3 2018. 1,102 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Signition LP reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Signition LP sold 894 Biogen shares in Q4 2019, an estimated $208K.
  • Signition LP first reported a position in Biogen in Q4 2017 and held it in 8 quarters.
  • Signition LP's Biogen position peaked at $9.18M in Q3 2018.
  • 1,102 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Signition LP's 13F filing for Q4 2019, filed 3 Feb 2020.